Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers

BACKGROUND: Prolyl hydroxylase 1 (PHD1) is a prognostic marker in several cancers. AIMS AND SCOPES: This study was undertaken to elucidate the clinical relevance of PHD1 in colorectal cancer (CRC) prognosis. MATERIALS AND METHODS: We compared PHD1 expression on a tissue microarray (TMA) containing s...

Descripción completa

Detalles Bibliográficos
Autores principales: Melling, Nathaniel, Grass, Julia, Reeh, Matthias, Tachezy, Michael, Blessmann, Marco, Nickel, Felix, Hackert, Thilo, Grupp, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374750/
https://www.ncbi.nlm.nih.gov/pubmed/36976352
http://dx.doi.org/10.1007/s00432-023-04717-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374750/
https://www.ncbi.nlm.nih.gov/pubmed/36976352
http://dx.doi.org/10.1007/s00432-023-04717-y

Ejemplares similares